Bank of Montreal’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-34,900
Closed -$30.6M 3776
2024
Q3
$30.6M Buy
+34,900
New +$31.4M 0.01% 624
2023
Q1
Sell
-42,700
Closed -$15.7M 4006
2022
Q4
$15.7M Buy
42,700
+41,700
+4,170% +$14.8M 0.01% 788
2022
Q3
$330 Buy
+1,000
New +$317K ﹤0.01% 2874
2020
Q1
Sell
-18,900
Closed -$2.48M 4418
2019
Q4
$2.48M Buy
+18,900
New +$2.19M ﹤0.01% 1751
2019
Q2
Sell
-1,500
Closed -$195K 4990
2019
Q1
$195K Buy
+1,500
New +$182K ﹤0.01% 2736
2017
Q1
Sell
-60,000
Closed -$4.03M 4099
2016
Q4
$4.03M Buy
+60,000
New +$4.47M ﹤0.01% 1175
2014
Q1
Sell
-1,042
Closed -$53K 4082
2013
Q4
$53K Buy
1,042
+42
+4% +$2.1K ﹤0.01% 2838
2013
Q3
$50K Hold
1,000
﹤0.01% 2824
2013
Q2
$49K Buy
+1,000
New +$54.4K ﹤0.01% 2731

Other funds holding LLY

Bank of Montreal's LLY Position: Q1 2026 in Review

Bank of Montreal reduced its Eli Lilly (LLY) stake by 7.5% in Q1 2026, selling an estimated $124M and leaving 1,507,369 shares worth $1.39B. The position accounts for 0.52% of the portfolio, ranked #38.

Bank of Montreal first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.75B in Q4 2025. 4,363 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Bank of Montreal held 1,507,369 shares of Eli Lilly worth $1.39B as of Q1 2026.
  • Bank of Montreal sold 122,082 Eli Lilly shares in Q1 2026, an estimated $124M.
  • Eli Lilly made up 0.52% of Bank of Montreal's portfolio in Q1 2026, its #38 holding.
  • Bank of Montreal first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • Bank of Montreal's Eli Lilly position peaked at $1.75B in Q4 2025.
  • 4,363 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Bank of Montreal's 13F filing for Q1 2026, filed 13 May 2026.